Lin Wu1, Wujian Xu2, Fangyu Wang1, Tangfeng Lv2, Zhiqiang Yin3, Yong Song4. 1. Department of Gastrointestinal Disease, Jinling Hospital, Nanjing, China. 2. Department of Respiratory Medicine, Jinling Hospital, 305 Zhongshan Road, Nanjing, China. 3. Chinese PLA 359 Hospital, 8 Zhongshan Road, Zhenjiang, China. yinzhiqiang359@163.com. 4. Department of Respiratory Medicine, Jinling Hospital, 305 Zhongshan Road, Nanjing, China. yong_song6310@yahoo.com.
Abstract
BACKGROUND: Specific plasma biomarkers in predicting pancreatic necrosis (PNec) are needed in treating acute pancreatitis (AP). AIMS: To investigate the prognostic value of plasma mitochondrial DNA fragments (mtDNA) in patient with AP for PNec. METHODS: AP patients with symptoms onset within 72 h were prospectively enrolled from June 2015 through June 2017 and were assessed for PNec using contrast-enhanced CT scan. Plasma mtDNA concentration (specific mitochondrial gene ND1) was measured using qRT-PCR. RESULTS: Of the 74 AP patients included, significant higher median level of plasma mtDNA was found in severe AP patients than in mild AP patients and healthy controls, but not in moderately severe AP patients. Patients with PNec had higher level of plasma mtDNA than those without PNec (774.2 [IQR 397.6-2205.0] vs. 169.5 [IQR 73.6-683.4] pg/ml, P < 0.05). The area under the receiver operator characteristic curve (ROC-AUC) of mtDNA for predicting PNec was higher than that of CRP (0.813 [95% CI 0.705-0.895] vs. 0.678 [95% CI 0.558-0.783]). Using a cutoff value of 302.5 pg/ml, the sensitivity and specificity for diagnosing PNec were 90.9 and 68.3%, respectively. Finally, plasma mtDNA levels decreased significantly after continuous renal replacement therapy (717.7 [IQR 307.00-1370.00] vs. 237.5 [IQR 117.20-464.80] pg/ml, P < 0.01). CONCLUSIONS: Elevated plasma mtDNA content in AP patients may be used as a more accurate early predictor of PNec in contrast to traditional CRP.
BACKGROUND: Specific plasma biomarkers in predicting pancreatic necrosis (PNec) are needed in treating acute pancreatitis (AP). AIMS: To investigate the prognostic value of plasma mitochondrial DNA fragments (mtDNA) in patient with AP for PNec. METHODS: AP patients with symptoms onset within 72 h were prospectively enrolled from June 2015 through June 2017 and were assessed for PNec using contrast-enhanced CT scan. Plasma mtDNA concentration (specific mitochondrial gene ND1) was measured using qRT-PCR. RESULTS: Of the 74 AP patients included, significant higher median level of plasma mtDNA was found in severe AP patients than in mild AP patients and healthy controls, but not in moderately severe AP patients. Patients with PNec had higher level of plasma mtDNA than those without PNec (774.2 [IQR 397.6-2205.0] vs. 169.5 [IQR 73.6-683.4] pg/ml, P < 0.05). The area under the receiver operator characteristic curve (ROC-AUC) of mtDNA for predicting PNec was higher than that of CRP (0.813 [95% CI 0.705-0.895] vs. 0.678 [95% CI 0.558-0.783]). Using a cutoff value of 302.5 pg/ml, the sensitivity and specificity for diagnosing PNec were 90.9 and 68.3%, respectively. Finally, plasma mtDNA levels decreased significantly after continuous renal replacement therapy (717.7 [IQR 307.00-1370.00] vs. 237.5 [IQR 117.20-464.80] pg/ml, P < 0.01). CONCLUSIONS: Elevated plasma mtDNA content in AP patients may be used as a more accurate early predictor of PNec in contrast to traditional CRP.
Entities:
Keywords:
Acute pancreatic necrosis; Acute pancreatitis; C-reactive protein; Mitochondrial DNA
Authors: Rossa W K Chiu; Lisa Y S Chan; Nicole Y L Lam; Nancy B Y Tsui; Enders K O Ng; Timothy H Rainer; Y M Dennis Lo Journal: Clin Chem Date: 2003-05 Impact factor: 8.327
Authors: Marjolein J A Weerts; Antoinette Hollestelle; Anieta M Sieuwerts; John A Foekens; Stefan Sleijfer; John W M Martens Journal: Clin Cancer Res Date: 2017-04-18 Impact factor: 12.531
Authors: Marcel P B Jansen; Wilco P Pulskens; Loes M Butter; Sandrine Florquin; Nicole P Juffermans; Joris J T H Roelofs; Jaklien C Leemans Journal: Shock Date: 2018-03 Impact factor: 3.454
Authors: Judita Knez; Vannina G Marrachelli; Nicholas Cauwenberghs; Ellen Winckelmans; Zhenyu Zhang; Lutgarde Thijs; Jana Brguljan-Hitij; Michelle Plusquin; Christian Delles; Daniel Monleon; Josep Redón; Jan A Staessen; Tim S Nawrot; Tatiana Kuznetsova Journal: PLoS One Date: 2017-07-13 Impact factor: 3.240
Authors: Thomas Zajonz; Christian Koch; Jan Schwiddessen; Melanie Markmann; Matthias Hecker; Fabian Edinger; Götz Schmidt; Andreas Boening; Michael Sander; Emmanuel Schneck Journal: J Clin Med Date: 2022-05-25 Impact factor: 4.964
Authors: Emese Réka Bálint; Gabriella Fűr; Lóránd Kiss; Dávid István Németh; Alexandra Soós; Péter Hegyi; Zsolt Szakács; Benedek Tinusz; Péter Varjú; Áron Vincze; Bálint Erőss; József Czimmer; Zoltán Szepes; Gábor Varga; Zoltán Rakonczay Journal: Sci Rep Date: 2020-10-21 Impact factor: 4.379